Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-13

Clinical Trial Update: Clostridium Difficile Vaccine Efficacy Trial [Phase 3]

View source ↗

Summary

Phase 3 trial results for a Clostridium difficile vaccine have been completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pfizer

Snippet

Sponsor: Pfizer | Conditions: Clostridium Difficile Infection | Phase 3 | Status: COMPLETED | Results posted: 2023-02-13